Valsartan salts

Details for Australian Patent Application No. 2005200648 (hide)

Owner Novartis AG

Inventors Marterer, Wolfgang; Buhlmayer, Peter; Oswald, Hans Rudolf; Marti, Erwin

Agent Davies Collison Cave

Pub. Number AU-A-2005200648

Parent 2001289672

Filing date 14 February 2005

Wipo publication date 3 March 2005

International Classifications

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 009/12 Drugs for disorders of the cardiovascular system

Event Publications

3 March 2005 Application Open to Public Inspection

  Published as AU-A-2005200648

3 March 2005 Complete Application Filed

11 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200649-Upgrading titaniferous materials

2005200647-Hybrid grafts